Valiant Organics Limited (VALIANTORG) AI Stock Analysis

• Market Cap: ₹5.73B
• Dividend Yield: N/A
• Average Volume (3M): 2.15K
• Price to Earnings (P/E): 52.6
• Beta (1Y): 0.75
• Revenue Growth: 16.43%
• EPS Growth: N/A
• Country: IN
• Employees: 1,073
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals
• EPS (TTM): 1.30
• Shares Outstanding: 28,019,610
• 10 Day Avg. Volume: 2,085
• 30 Day Avg. Volume: 2,152
• PEG Ratio: 3.90
• Price to Book (P/B): 1.13
• Price to Sales (P/S): 1.14
• P/FCF Ratio: 31.87
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 46 Neutral
• Price Target: ₹200.00 ▼(-28.57% Downside)
• Action: Reiterated Date: 11/21/25
• Date: Action: Reiterated 11/21/25

Valiant Organics Limited's overall stock score is primarily impacted by its weak financial performance and bearish technical indicators. The company's high P/E ratio, despite financial challenges, suggests overvaluation. The absence of earnings call data and corporate events leaves the focus on the need for improved profitability and market sentiment.

Positive Factors

Diversified End‑market Exposure

Valiant's customer mix across agrochemicals, pharmaceuticals, dyes and other specialty chains reduces concentration risk and smooths demand cycles. End markets like pharma and agrochemicals provide durable underlying demand for intermediates, supporting stable revenue over months.

Specialty chemicals business model

A focus on organic intermediates reflects technical know‑how and customer integration, which often creates higher switching costs and long‑term supply relationships. This structural positioning supports margin resilience and repeatable order flow over a multi‑month horizon.

Reasonable equity position

An equity base that exceeds liabilities provides capital buffer and loss absorption capacity. That structural strength improves the firm's ability to fund working capital and investments or access capital markets if needed, enhancing financial flexibility over time.

Negative Factors

Significant leverage

Material leverage raises fixed interest obligations and reduces financial flexibility. In a capital‑intensive chemicals business, high debt makes the company sensitive to cash‑flow volatility, constraining reinvestment and increasing default risk if operating performance weakens.

Weak & inconsistent cash generation

Declining and inconsistent operating and free cash flow limit the company's ability to service debt, fund capex, and support working capital. Over several months this reduces resilience to shocks and hampers strategic initiatives or recovery investments.

Declining revenue and negative profitability

Sustained revenue declines and negative net margins undermine internal funding and long‑term viability of growth plans. Even with some gross margin improvement, persistent negative EBIT/EBITDA prevents rebuilding retained earnings and restricts strategic reinvestment.

Valiant Organics Limited Business Overview & Revenue Model

Company Description

Valiant Organics Limited, a chemical manufacturing company, manufactures and markets specialty chemicals in India. Its products include para chlorophenol; ortho chlorophenol; 2,4 di-chlorophenol; 2,4,6 tri- chlorophenol; 2,6 di-chlorophenol; and para nitroaniline. The company's products also comprise ortho chloro para nitro aniline, 6 acetyl OAPSA, OA acetanilide, and PA acetanilide; ortho anisidine, para anisidine, ortho toluidine, para toluidine, IPPCA, FI aniline, and meta chloro aniline; acids; para and ortho amino phenol; and ortho and para nitro anisole. Its products are primarily used as intermediates in agro chemicals, dyes, pigments, pharmaceuticals, cosmetics, specialty chemicals, polymer, and veterinary drugs. The company also exports its products to Europe, Asia, and the United States. Valiant Organics Limited was founded in 1984 and is based in Mumbai, India.

How the Company Makes Money

null

Valiant Organics Limited Financial Statement Overview

Summary

Valiant Organics Limited faces challenges with declining revenue and profitability, as well as inconsistent cash flow generation. While the balance sheet reflects a reasonable equity position, the high leverage and declining equity trend are concerning. The company needs to focus on improving profitability and stabilizing cash flows to enhance its financial health.

Income Statement

Valiant Organics Limited has experienced declining revenue over the past few years, with a significant decrease in net income from positive to negative territory. The company shows a negative net profit margin, indicating profitability issues. The gross profit margin has improved recently, but overall profitability remains weak with negative EBIT and EBITDA margins in the latest period.

Balance Sheet

The balance sheet presents a reasonable equity ratio, suggesting a solid asset base relative to liabilities. However, the debt-to-equity ratio indicates significant leverage, which poses potential financial risk. While stockholders' equity exceeds total debt, the declining trend in equity raises concerns about balance sheet robustness.

Cash Flow

The company shows a declining trend in operating cash flow, and free cash flow has been inconsistent, with recent periods showing a decrease. The free cash flow to net income ratio is concerning due to negative net income. Although there is some positive operating cash flow, the overall cash flow position is weak, with potential liquidity challenges.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	7.52B	7.19B	7.23B	10.52B	11.53B	7.55B
Gross Profit	2.67B	2.62B	470.01M	1.81B	2.17B	2.19B
EBITDA	895.07M	615.51M	425.75M	1.77B	2.12B	2.11B
Net Income	235.33M	-37.36M	-83.91M	881.21M	1.13B	1.15B
Balance Sheet
Total Assets	11.63B	11.83B	12.48B	12.39B	11.92B	8.76B
Cash, Cash Equivalents and Short-Term Investments	107.93M	131.53M	71.02M	456.71M	499.47M	349.85M
Total Debt	2.36B	2.49B	2.57B	2.74B	3.63B	2.09B
Total Liabilities	4.23B	4.58B	5.19B	4.99B	5.43B	3.68B
Stockholders Equity	7.40B	7.25B	7.29B	6.89B	6.13B	5.02B
Cash Flow
Free Cash Flow	797.52M	256.03M	90.70M	862.19M	-1.53B	-562.54M
Operating Cash Flow	922.42M	564.32M	840.00M	2.38B	-307.47M	1.15B
Investing Cash Flow	-702.45M	-209.61M	-649.88M	-1.43B	-1.24B	-1.59B
Financing Cash Flow	-230.76M	-318.13M	-231.19M	-1.12B	1.67B	486.70M

Valiant Organics Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 280.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VALIANTORG, the sentiment is Negative. The current price of 280 is above the 20-day moving average (MA) of 227.42, above the 50-day MA of 244.74, and below the 200-day MA of 321.59, indicating a bearish trend. The MACD of -11.87 indicates Positive momentum. The RSI at 27.21 is Positive, neither overbought nor oversold. The STOCH value of 19.11 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:VALIANTORG.

Valiant Organics Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BHARATWIRE	76 Outperform	₹10.56B	17.06	―	―	8.45%	-14.27%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
EVERESTIND	55 Neutral	₹5.50B	-5.44	―	0.50%	-3.11%	-331.77%
HERANBA	49 Neutral	₹6.88B	-10.64	―	0.39%	―	―
DECCANCE	48 Neutral	₹9.12B	-467.16	―	0.08%	-28.32%	93.44%
FAIRCHEMOR	47 Neutral	₹6.52B	-2,425.33	―	1.07%	-22.10%	-85.56%
VALIANTORG	46 Neutral	₹5.73B	52.56	―	―	16.43%	―